HEALTH OF WOMAN. 2020.8(154): 17–23; doi 10.15574/HW.2020.154.17
Zhuk S. I.¹, Nochvina O. A.^2
1Shupyk National Medical Academy of Postgraduate Education, Kiev
²Vinnitsa national medical University M. I. Pirogov

The objective: to determine the optimal prophylactic and therapeutic drug to support and restore the biphasic menstrual cycle against the background of the influence of chronic stress.
Materials and methods. A comparative study of the effectiveness of the use of preparations of dry extract of common rod (Vitex Agnus castus ) BNO 1095 and various vitamin complexes with a sedative effect, which contain vitamins of group B, magnesium, folic acid, herbal preparations of valerian, pasiflora, was carried out. The hormonal profile and psychoemotional state in women with dyshormonal disorders in modern conditions were studied.
Results. The clinical efficacy and feasibility of using the drug Vitex Agnus castus in women with dyshormonal disorders in conditions of psychoemotional disadaptation due to the harmonizing effect on the concentration of female sex hormones, normalizing the ratio of gonadotropic hormones, eliminating the estradiol / progesterone imbalance against the background of a decrease in prolactin level has been proven.
Conclusion. The presented results of the study prove the effectiveness of the use of the phytopreparation Vitex Agnus castus in women with dyshormonal disorders under conditions of chronic stress due to its dopaminergic effect on psychoemotional status as a result of elimination of latent stress-induced hyperprolactinemia, comparable to the effect of synthetic inhibitors of prolactin secretion.
In addition, the drug Vitex Agnus castus can be prescribed to prevent the occurrence of phase inconsistency in the secretion of gonadotropic hormones due to the activation of stress-limiting systems and local neuroendocrine modulators, which helps to reduce stress stress.
Keywords: dyshormonal disorders, chronic stress, maladjustment.

REFERENCES

1. Bulganina OV. 2013. Optimizatsiya lecheniya narusheniy menstrualnoy funktsii tsentralnogo geneza u devochek pubertatnogo vozrasta. Avtoref. dis. kand. med. nauk: spets. 14.01.01 «Akusherstvo i ginekologiya». Novosibirsk:18.

2. Bugaevskiy KA. 2017. Gipomenstrualnyy syndrom u devochek-podrostkov pri zanyatii ryadom vidov sporta. MaterIali naukovogo simpoziumu z mizhnarodnoyu uchastyu «Gipomenstrualniy sindrom u divchatok-pidlitkiv (patogenez, profIlaktika, viddaleni naslidky)». Harkiv:8–9.

3. Ventskovskaya IB, Efimenko OA. 2003. Giperprolaktinemicheskie sostoyaniya v praktike ginekologa i metody ih lecheniya. Reproduktivnoe zdorove zhenschiny 3(15):71–76.

4. Zhuk SI. 2017. Pregravidarnaya pogotovka zhenschin s disgormonalnymi narusheniyami reproduktivnoy sistemy. Zdorove zhenschiny 2(118):17–22.

5. Serov VN, Prilepskaya VN, Ovsyanikova TV. 2006. Ginekologicheskaya endokrinologiya. M, MEDpress-inform:520.

6. Smetnik VP, Butareva LB. 2009. Opyit primeneniya fitoprepatata Tsiklodinon u patsientok s nedostatochnostyu zheltogo tela i giperprolaktinemiey. Meditsinskie novosti 2:49–52.

7. Stepanova EA, Kolesnikov SI. 2012. Narusheniya menstrualnogo tsikla u devochek-podrostkov s displaziey soedinitelnoy tkani. Byulleten VSNTs SO RAMN 2(84);ch. 2:49–53.

8. Tatarchuk TF. 2006. Stress i reproduktivnaya funktsiya zhenschiny. Mezhdunar. endokrinol. zhurn. 3(5):2–9.

9. Tatarchuk TF. 2008. Sposib zhyttia ta gormonalnyi homeostaz u zhinok rannoho reproduktyvnoho viku. Zb.nauk.prats Asotsiatsii akusheriv-ginekologiv Ukrainy. K, Intermed:700–704.

10. Tatarchuk TF, Ventskovskaya IB, Shevchuk TV. 2007. Sovremennyiy vzglyad na mehanizmyi razvitiya, diagnostiku i lechenie predmenstrualnyih rasstroystv. Mezhdunarodnyy endokrinologicheskiy zhurnal 1(7):51–58.

11. Tatarchuk TF. 2009. Shkala otsenki perezhivaniya stressa Perceived Stress Scale (PSS): osnovnyie etapyi adaptatsii dlya zhenskogo naseleniya Ukrainy. Zb.nauk.prats Asotsiatsii akusheriv-ginekologiv Ukrainy. K, Intermed:606–613.

12. Shamina IV, Dudkova GV. 2014. Kompleksnyy podhod k problemam stanovleniya reproduktivnoy funktsii u devochek. Novye vozmozhnosti primeneniya fitopreparatov. Ginekologiya 4:28–32.

13. Ader DN, Shriver CD. 1997, Nov. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg. 185(5):466-70. https://doi.org/10.1016/S1072-7515(97)00095-1

14. Chrousos GP. 1998. Interactions between the Hypotalamic-Pituitary Adrenal axis and the Female Reproductive System. Annals of Internal Medicine 129;3:229-240. https://doi.org/10.7326/0003-4819-129-3-199808010-00012; PMid:9696732

15. Deuster PA, Ader DN South-Paul J Adera. 2001. Cyclical mastalgia: prevalence and associated health and behavioral factors. Psychosorn Obstet Cynecol. 22:71-76. https://doi.org/10.3109/01674820109049956; PMid:11446156

16. Dobson H, Ghuman S, Prabhakar S. 2003. A conceptual model of the influence of stress on female reproduction. Reproduction 125:151-163. https://doi.org/10.1530/rep.0.1250151; PMid:12578529

17. Halaska M, Beles P, Gorkow C, Sieder C. 1999. Treatment of cyclical mastalgia with a solution containing an extract of Vitex agnus castus: Recent results of a placebo-controlled double blind study. The Breast. 8:175-181. https://doi.org/10.1054/brst.1999.0039; PMid:14731436

18. Leon Speroff, Robert H. Glass, Nathan G. Kase. 2006. Clinical Gynecological Endocrinology and Infertility.

19. Millet AV, Dirbas FM. 2002, Jul. Clinical management of breast pain: a review. Obstet Gynecol Surv. 57(7):451-61. https://doi.org/10.1097/00006254-200207000-00022; PMid:12172222

20. Srivastava A. Evidence-based management of Mastalgia: A meta-analysis of randomised trials. The Breast. 16;Issue 5:503-512. https://doi.org/10.1016/j.breast.2007.03.003; PMid:17509880

21. Wuttke W, Splitt G, Gorkow C, Sieder С. 1997. Treatment of cyclical mastalgia with medicinal product containing Agnus castus. Results of a randomized, placebo-controlled, double blind study. Geburtsh. U. Frauenheilk. 57:569-574. https://doi.org/10.1055/s-2007-1023139